Release Date: 31/10/12 18:26 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 24.23KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%